US20220372092A1
University of Texas System
Provided herein are tumor-antigen VCX/Y specific peptides. Also provided herein are methods of generating VCX/Y-specific immune cells and their use for the treatment of cancer. Immunogenic compositions comprising VCX/Y-specific peptides are also provided. In a further embodiment, there is provided …